A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants
NCT06627556 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2024-10-04
Summary
The primary purpose of this study is to evaluate the safety and tolerability of H021 tablets following oral administration of single and multiple ascending doses in healthy participants.
Conditions
Interventions
- DRUG
-
H021
H021 oral tablet.
- DRUG
-
H021 Placebo
H021 placebo oral tablet.
Sponsors & Collaborators
-
Jiangsu Carephar Pharmaceutical Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-09-17
- Primary Completion
- 2025-02-27
- Completion
- 2025-02-27
Countries
- Australia
Study Locations
More Related Trials
-
A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food Effects
NCT06175949 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Multiple Dose Study to Assess the Safety and Tolerability of BMS-986166 in Healthy Volunteers
NCT03038711 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC)
NCT05975047 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Study of HMPL-004 in Subjects With Crohn's Disease
NCT00655733 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis
NCT02985593 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease
NCT07229950 ·Status: RECRUITING ·Phase: PHASE2
-
A Study for HSK47388 in Participants With Ulcerative Colitis
NCT07335055 ·Status: RECRUITING ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
NCT01164904 ·Status: TERMINATED ·Phase: PHASE1
-
Confirmatory Clinical Study in Active Ulcerative Colitis
NCT07296315 ·Status: RECRUITING ·Phase: PHASE2
-
Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis
NCT05486104 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis
NCT07083193 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis
NCT00572585 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis
NCT06681389 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis
NCT04096573 ·Status: WITHDRAWN ·Phase: PHASE2
-
Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy Subjects
NCT04360343 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
NCT02065622 ·Status: COMPLETED ·Phase: PHASE3
-
Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose
NCT00868660 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
NCT02958865 ·Status: COMPLETED ·Phase: PHASE2
-
Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis
NCT02864264 ·Status: TERMINATED ·Phase: PHASE1
-
A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
NCT01221818 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis
NCT00073021 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002)
NCT04924114 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis
NCT06080048 ·Status: COMPLETED ·Phase: PHASE1
-
MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients
NCT01959165 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis
NCT05377580 ·Status: COMPLETED ·Phase: PHASE2